Routine preoperative testing for cataract surgery doesn’t improve outcomes, but are patients being tested anyway? Medscape Optometry
Solar-Related Eye Tumor Diagnosis Difficult in Low-Resource Settings
Clinical features do not reliably distinguish ocular surface squamous neoplasia (OSSN) from benign conjunctival lesions when histology can’t be evaluated, and toluidine blue vital staining is good for screening but not for diagnosis, a study from Kenya…
Doctors Urged to Practice ‘Conservative Diagnosis’
(MedPage Today) — And sharing cell phone numbers is a good idea
Uncategorized
Ophthalmic community grieves Jan Worst, leader in IOL innovation
Jan Worst, MD, a leader in IOL innovation, died Friday, Sept. 25, in his hometown of Groningen, the Netherlands, surrounded by his family. Worst was trained as an ophthalmologist during the years when Sir Harold Ridley was fighting a hard battle to persuade the scientific community that an artificial lens could be implanted in the eye. Cornelius Binkhorst, MD, a great advocate of Ridley and inventor of the iris clip lens, was his “teacher and inspirer,” as Worst himself used to say.
Uncategorized
Ocular Therapeutix submits NDA for Dextenza to treat postop ocular pain
Ocular Therapeutix submitted a new drug application to the FDA for Dextenza to treat ocular pain after ophthalmic surgery, according to a press release. “This represents Ocular Therapeutix’s first NDA filing with the FDA and is an important development milestone as we advance our broad-based programs for the treatment of ocular diseases and conditions through clinical development and potential commercialization pending FDA approval,” Amar Sawhney, PhD, president, CEO and chairman of Ocular Therapeutix, said in the release.
Age-related blindness cure steps closer with new stem cell trial
Researchers have successfully transplanted eye cells derived from stem cells into a patient with the hope of curing vision loss caused by wet age-related macular degeneration.